146 results on '"Sgariglia, Roberta"'
Search Results
2. Multiplex digital colour-coded barcode technology on RNA extracted from routine cytological samples of patients with non-small cell lung cancer: pilot study
3. UbcH10 Expression Can Predict Prognosis and Sensitivity to the Antineoplastic Treatment for Colorectal Cancer Patients
4. EGFR mutant allelic-specific imbalance assessment in routine samples of non-small cell lung cancer
5. KRAS Mutant Allele-Specific Imbalance (MASI) assessment in routine samples of patients with metastatic colorectal cancer
6. Ion Torrent next-generation sequencing for routine identification of clinically relevant mutations in colorectal cancer patients
7. Methods for actionable gene fusion detection in lung cancer: now and in the future
8. Evaluation of Micro Satellite Instability and Mismatch Repair Status in Different Solid Tumors: A Multicenter Analysis in a Real World Setting
9. Liquid Biopsy Analysis in Clinical Practice: Focus on Lung Cancer
10. Molecular Testing of Thyroid Fine-Needle Aspiration: Local Issues and Solutions. An Interventional Cytopathologist Perspective
11. Liquid Biopsy Is a Promising Tool for Genetic Testing in Idiopathic Pulmonary Fibrosis
12. RNA-Based Assay for Next-Generation Sequencing of Clinically Relevant Gene Fusions in Non-Small Cell Lung Cancer
13. Moving towards a local testing solution for undetermined thyroid fine-needle aspirates: validation of a novel custom DNA-based NGS panel.
14. Next generation sequencing in cytology
15. Moving towards a local testing solution for undetermined thyroid fine-needle aspirates: validation of a novel custom DNA-based NGS panel
16. TargetPlex FFPE-Direct DNA Library Preparation Kit for SiRe NGS panel: an international performance evaluation study
17. Performance evaluation of a fully closed real-time PCR platform for the detection of KRAS p.G12C mutations in liquid biopsy of patients with non-small cell lung cancer
18. Next Generation Sequencing in Cytopathology: Focus on Non-Small Cell Lung Cancer
19. RNA-Based Assay for Next-Generation Sequencing of Clinically Relevant Gene Fusions in Non-Small Cell Lung Cancer
20. EGFR mutation detection by microfluidic technology: a validation study
21. TargetPlex FFPE-Direct DNA Library Preparation Kit for SiRe NGS panel: an international performance evaluation study.
22. Performance evaluation of a fully closed real-time PCR platform for the detection of KRAS p.G12C mutations in liquid biopsy of patients with non-small cell lung cancer.
23. Tumor mutational burden on cytological samples: A pilot study
24. Thyroid fine-needle aspiration trends before, during, and after the lockdown: what we have learned so far from the COVID-19 pandemic
25. Liquid biopsy for BRAF mutations testing in non-small cell lung cancer: a retrospective study
26. BRAF: A Two-Faced Janus
27. KRAS mutations testing in non-small cell lung cancer: the role of Liquid biopsy in the basal setting
28. Predictive molecular pathology in the time of COVID-19
29. Harmonization of Next-Generation Sequencing Procedure in Italian Laboratories: A Multi-Institutional Evaluation of the SiRe® Panel
30. A 45‐Year Old Man With An Intraventricular Mass
31. Rapid On‐site Molecular Evaluation in thyroid cytopathology: A same‐day cytological and molecular diagnosis
32. Implications of U.S. monetary policy normalization on international capital flows : evidence from South Korea
33. Tumor mutational burden on cytological samples: A pilot study.
34. Predictive molecular pathology in the time of COVID-19.
35. Young investigator challenge: Can the Ion AmpliSeq Cancer Hotspot Panel v2 be used for next-generation sequencing of thyroid FNA samples?
36. DEVELOPMENT, VALIDATION, COMPARISON AND CLINICAL IMPLEMENTATION OF DIFFERENT MULTIGENE ASSAYS FOR THE PRE-SURGICAL RISK STRATIFICATION OF INDETERMINATE THYROID FINE NEEDLE ASPIRATIONS.
37. Liquid biopsy for BRAF mutations testing in non-small cell lung cancer: a retrospective study.
38. UbcH10 expression can predict prognosis and sensitivity to the antineoplastic treatment for colorectal cancer patients
39. Evaluation of BRAF, RAS, RET/PTC, and PAX8/PPARg alterations in different Bethesda diagnostic categories: A multicentric prospective study on the validity of the 7‐gene panel test in 1172 thyroid FNAs deriving from different hospitals in South Italy
40. Performance analysis of SiRe next-generation sequencing panel in diagnostic setting: focus on NSCLC routine samples
41. Different qualifiers of AUS/FLUS thyroid FNA have distinct BRAF , RAS , RET /PTC , and PAX8 /PPARg alterations
42. Cell free DNA analysis by SiRe® next generation sequencing panel in non small cell lung cancer patients: focus on basal setting
43. Development of a gene panel for next-generation sequencing of clinically relevant mutations in cell-free DNA from cancer patients
44. P2.01-008 SiRe Next Generation Sequencing Panel: Effective Diagnostic Tool for Circulating Free DNA Analysis
45. Liquid biopsy for BRAFmutations testing in non-small cell lung cancer: a retrospective study
46. Performance analysis of SiRe next-generation sequencing panel in diagnostic setting: focus on NSCLC routine samples.
47. Young investigator challenge: Can the Ion AmpliSeq Cancer Hotspot Panel v2 be used for next-generation sequencing of thyroid FNA samples?
48. Less frequently mutated genes in colorectal cancer: evidences from next-generation sequencing of 653 routine cases
49. Different qualifiers of AUS/FLUS thyroid FNA have distinct BRAF, RAS, RET/PTC, and PAX8/PPARg alterations.
50. UbcH10 expression can predict prognosis and sensitivity to the antineoplastic treatment for colorectal cancer patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.